Brief: Biosyent Inc Says Has Signed An Exclusive License And Supply Agreement With Aft Pharmaceuticals
25/11/2019 23:27
Nov 25 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* BIOSYENT INC - HAS SIGNED AN EXCLUSIVE LICENSE AND SUPPLY
AGREEMENT WITH AFT PHARMACEUTICALS
* BIOSYENT INC - INTENDS TO LAUNCH COMBOGESIC PRODUCT IN
2020
Source text for Eikon: ID:nGNX7t8JN9
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid